IT’S hard to imagine a time when the word ‘Ozempic’ wasn’t part of our vocabulary.  For years, celebs have embraced the ...

Dwindling supplies of Ozempic are fuelling an “exploding” black market for the drug across Australia, as the medical industry is forced to assess which patients need the popular medication the most.

COMMENT: The new craze of using lower-than-recommended dosages of weight loss drugs to slim down might sound tempting, says ...

Health experts are concerned Ozempic and other GLP-1 agonist drugs may be inappropriately prescribed to people experiencing ...

Weight-loss jabs have become so popular that recent figures suggest that over half a million people are taking either ...

Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.

Weight loss drugs users should be more cautious when taking their item of choice, top medics warn. after 82 deaths link to the substances.

Recent research throws into question whether GLP-1 drugs increase the risk of certain types of thyroid cancer.

Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

Novo Nordisk announced launching a direct-to-patient online pharmacy NovoCare, offering a more than half-price cut for its ...

The FDA last month removed Novo Nordisk's competing drugs Wegovy and Ozempic from the shortage list, and compounders have ...

NovoCare Pharmacy will provide all dose strengths of Wegovy at a reduced cost of $499 per month for cash-paying patients ...